Secant Medical to Present during the Advances in Tissue Engineering 2014 22nd Annual Short Course at Rice University
PERKASIE, Pa.--(BUSINESS WIRE)--Secant Medical will present at Rice University’s Advances in Tissue Engineering 2014 22nd Annual Short Course in Houston, August 13-16. Jeremy Harris, Ph.D., Technical Director at Secant Medical, will discuss how the company is scaling up poly(glycerol sebacate) (PGS) from academia to commercialization, along with the obstacles faced during the process, such as ensuring quality and consistency in every product batch.
“There is a common goal to get technology out of the lab. Secant Medical understands this and has put together a cross-functional team with backgrounds ranging from regulatory and quality to biomaterials research and business development, to accomplish our goal of commercializing PGS.”
The presentation, “Research Challenges Associated with Creating a Marketable Polymer Technology”, takes place on Friday, August 15 at 11:20 am.
“The audience for this short course shares our interest in translating technology from the academic world to the commercial world,” said Jeremy Harris, Ph.D. “There is a common goal to get technology out of the lab. Secant Medical understands this and has put together a cross-functional team with backgrounds ranging from regulatory and quality to biomaterials research and business development, to accomplish our goal of commercializing PGS.”
About Advances in Tissue Engineering: The 22nd Annual Short course focuses on advances in the science and technology of tissue engineering and features leading scientists from Rice University, the Texas Medical Center, industry, and other institutions. The course includes the latest on patient-specific therapeutics featuring speakers from academia, medical research, and industry. The course topics include cell adhesion, adhesion molecules, growth factors, extracellular matrix analogs, polymer scaffolds, cell transplantation, and nanobiotechnology.
About Secant Medical: Secant Medical provides advanced biomaterials and biomedical textile structures to the medical device industry. We partner with clients to design, develop, and manufacture high-performance biomedical structures for applications in cardiovascular, neurovascular, orthopedic and general surgery. Built on a 70-year history, we’re committed to the future of regenerative medicine and actively engage in research partnerships to advance next-generation biomaterial technology into practical applications for the medical device and pharmaceutical industries. Secant Medical is a business unit of Fenner PLC, a worldwide leader in reinforced polymer engineering headquartered in Yorkshire, England. For more information, contact Maria Fontanazza at 215-257-8680 x2192 or email@example.com; or visit www.secantmedical.com.